Literature DB >> 24478522

Reply to "described diagnostic inconsistencies were observed with an obsolete version of the Xpert MTB/RIF assay and are unlikely to recur in the current version of the assay".

Akos Somoskovi1, Guido V Bloemberg.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24478522      PMCID： PMC3911306          DOI： 10.1128/JCM.02682-13

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  1 in total

1.  Diagnostic implications of inconsistent results obtained with the Xpert MTB/Rif assay in detection of Mycobacterium tuberculosis isolates with an rpoB mutation associated with low-level rifampin resistance.

Authors:  Akos Somoskovi; Vanessa Deggim; Diana Ciardo; Guido V Bloemberg
Journal:  J Clin Microbiol       Date:  2013-07-12       Impact factor: 5.948
  1 in total
  3 in total

1.  On the Consequences of Poorly Defined Breakpoints for Rifampin Susceptibility Testing of Mycobacterium tuberculosis Complex.

Authors:  Claudio U Köser; Sophia B Georghiou; Thomas Schön; Max Salfinger
Journal:  J Clin Microbiol       Date:  2021-03-19       Impact factor: 5.948

2.  Reply to "molecular diagnosis of rifampin-monoresistant tuberculosis in Indian patients: problems with a discordance analysis".

Authors:  Sarman Singh; Syed Beenish Rufai; Parveen Kumar; Jitendra Singh
Journal:  J Clin Microbiol       Date:  2014-09       Impact factor: 5.948

3.  Genotypic, Phenotypic and Clinical Validation of GeneXpert in Extra-Pulmonary and Pulmonary Tuberculosis in India.

Authors:  Urvashi B Singh; Pooja Pandey; Girija Mehta; Anuj K Bhatnagar; Anant Mohan; Vinay Goyal; Vineet Ahuja; Ranjani Ramachandran; Kuldeep S Sachdeva; Jyotish C Samantaray
Journal:  PLoS One       Date:  2016-02-19       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.